Lijun Wu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Mitochondrial Dna

Liver Metastases

Computed Tomography

Top Venues

Communications biology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Zhihai Zheng, Youjuan Zhao, Hongjia Yu, Tingting Wang, Jinhai Li, Liang Xu, Chunming Ding, Lan He, Lijun Wu, Zhixiong Dong
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications biology 7 (1) (2024)
Zhihai Zheng, Youjuan Zhao, Hongjia Yu, Tingting Wang, Jinhai Li, Liang Xu, Chunming Ding, Lan He, Lijun Wu, Zhixiong Dong
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications biology 7 (1) (2024)
Zhihai Zheng, Youjuan Zhao, Hongjia Yu, Tingting Wang, Jinhai Li, Liang Xu, Chunming Ding, Lan He, Lijun Wu, Zhixiong Dong
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications biology 7 (1) (2024)
Zhihai Zheng, Youjuan Zhao, Hongjia Yu, Tingting Wang, Jinhai Li, Liang Xu, Chunming Ding, Lan He, Lijun Wu, Zhixiong Dong
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications biology 7 (1) (2024)
Zhihai Zheng, Youjuan Zhao, Hongjia Yu, Tingting Wang, Jinhai Li, Liang Xu, Chunming Ding, Lan He, Lijun Wu, Zhixiong Dong
Suppressing MTERF3 inhibits proliferation of human hepatocellular carcinoma via ROS-mediated p38 MAPK activation. Communications biology 7 (1) (2024)
Zhiyuan Bo, Bo Chen, Zhengxiao Zhao, Qikuan He, Yicheng Mao, Yunjun Yang, Fei Yao, Yi Yang, Ziyan Chen, Jinhuan Yang, Haitao Yu, Jun Ma, Lijun Wu, Kaiyu Chen, Luhui Wang, Mingxun Wang, Zhehao Shi, Xinfei Yao, Yulong Dong, Xintong Shi, Yunfeng Shan, Zhengping Yu, Yi Wang, Gang Chen
Prediction of response to lenvatinib monotherapy for unresectable hepatocellular carcinoma by machine learning radiomics: A multicenter cohort study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)